Belite Bio (BLTE) Stock News
$BLTE · NASDAQ · 1 stories in 30 days$143.78
1D +0.70%
BORSA has published 1 story on Belite Bio (BLTE) in the past 30 days. BORSA’s news read on BLTE is bullish at 62/100, based on 1 company event over the past 7 days. BLTE last closed at $154.49 on Oct 9, down 3.18% over five sessions and down 11.76% over the past month. Belite Bio’s next earnings report is scheduled for Monday, Nov 9.
The wire on $BLTE
newest first · updated · direct subject stories onlyBelite Bio uplists to Nasdaq Global Select Market
Belite Bio (BLTE) received approval to move its listing to the Nasdaq Global Select Market, the exchange's highest tier. Trading starts today under the same ticker. The company says the uplisting reflects stronger financial and liquidity standards and may improve institutional visibility.
bullish 65 · impact 30